{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-000643","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.682570+00:00","generated_at":"2026-05-16T04:27:43.359527+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Profound Medical announces PRO FAMILIA hospital completes 500th Sonalleve procedure","bullets":["PRO FAMILIA Specialist Hospital in Rzeszów, Poland performed its 500th Sonalleve MRI-guided focused ultrasound procedure.","Sonalleve provides non-surgical treatment for uterine fibroids and adenomyosis, with no incisions, no blood loss, and no overnight stay.","Over 4,000 women treated globally with 10 Sonalleve devices in Europe, China, and Southeast Asia.","CEO Arun Menawat notes Sonalleve international growth while U.S. focus remains on TULSA-PRO commercialization.","Approximately $10 million in research grants from European and Canadian organizations over five years for Sonalleve studies."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-000643","json":"https://secwatch.observer/filing/0001171843-26-000643.json","markdown":"https://secwatch.observer/filing/0001171843-26-000643.md","text":"https://secwatch.observer/filing/0001171843-26-000643.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326000643/0001171843-26-000643-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326000643/f8k_020526.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:27:43.359527+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}